These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23917253)

  • 1. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
    Plum S; Helling S; Theiss C; Leite REP; May C; Jacob-Filho W; Eisenacher M; Kuhlmann K; Meyer HE; Riederer P; Grinberg LT; Gerlach M; Marcus K
    J Proteomics; 2013 Dec; 94():202-206. PubMed ID: 23917253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of neuromelanin granules.
    Tribl F
    Curr Protoc Cell Biol; 2008 Dec; Chapter 3():Unit 3.31. PubMed ID: 19085988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.
    Plum S; Steinbach S; Attems J; Keers S; Riederer P; Gerlach M; May C; Marcus K
    Sci Rep; 2016 Nov; 6():37139. PubMed ID: 27841354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes.
    Wulf M; Barkovits K; Schork K; Eisenacher M; Riederer P; Gerlach M; Eggers B; Marcus K
    J Neural Transm (Vienna); 2022 Oct; 129(10):1257-1270. PubMed ID: 35852604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules.
    Wulf M; Barkovits-Boeddinghaus K; Sommer P; Schork K; Eisenacher M; Riederer P; Gerlach M; Kösters S; Eggers B; Marcus K
    J Vis Exp; 2021 Dec; (178):. PubMed ID: 34978295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson's Disease.
    Plum S; Eggers B; Helling S; Stepath M; Theiss C; Leite REP; Molina M; Grinberg LT; Riederer P; Gerlach M; May C; Marcus K
    Cells; 2020 Dec; 9(12):. PubMed ID: 33276480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.
    Tribl F; Asan E; Arzberger T; Tatschner T; Langenfeld E; Meyer HE; Bringmann G; Riederer P; Gerlach M; Marcus K
    Mol Cell Proteomics; 2009 Aug; 8(8):1832-8. PubMed ID: 19318681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
    PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.
    Korzhevskii DE; Kirik OV; Guselnikova VV; Tsyba DL; Fedorova EA; Grigorev IP
    Eur J Histochem; 2021 Sep; 65(s1):. PubMed ID: 34468106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI T
    Lee H; Baek SY; Kim EJ; Huh GY; Lee JH; Cho H
    Neuroimage; 2020 May; 211():116625. PubMed ID: 32058001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.
    Fasano M; Giraudo S; Coha S; Bergamasco B; Lopiano L
    Neurochem Int; 2003 Jun; 42(7):603-6. PubMed ID: 12590943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Subcellular proteomics" of neuromelanin granules isolated from the human brain.
    Tribl F; Gerlach M; Marcus K; Asan E; Tatschner T; Arzberger T; Meyer HE; Bringmann G; Riederer P
    Mol Cell Proteomics; 2005 Jul; 4(7):945-57. PubMed ID: 15851778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.
    Tribl F; Marcus K; Meyer HE; Bringmann G; Gerlach M; Riederer P
    J Neural Transm (Vienna); 2006 Jun; 113(6):741-9. PubMed ID: 16755378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.
    Kitao S; Matsusue E; Fujii S; Miyoshi F; Kaminou T; Kato S; Ito H; Ogawa T
    Neuroradiology; 2013 Aug; 55(8):947-953. PubMed ID: 23673875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
    Faucheux BA; Martin ME; Beaumont C; Hauw JJ; Agid Y; Hirsch EC
    J Neurochem; 2003 Sep; 86(5):1142-8. PubMed ID: 12911622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.